Dr. Kathy Rouan

• Healthcare
• Pharma & Biotech
• United Kingdom

GSK: Stiefel to start phase III study of subcutaneous ofatumumab in patients with rare autoimmune skin disorder pemphigus vulgaris

LONDON, 9-10-2014 — /EuropaWire/ — Stiefel, a GSK company, today announced the start of a phase III study to evaluate…